Cancer control—A global perspective

Disparities in cancer control exist in low‐ and middle‐income countries (LMICs). Many countries do not have cancer registries to record incidence, mortality and prevalence and are reliant on Globocan estimates of their cancer burden. Poorer cancer control within and between countries occurs in those...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer care 2017-01, Vol.26 (1), p.e12654-n/a
Main Author: Olver, I.
Format: Article
Language:English
Subjects:
Cancer
cancer control
cancer medicines
Developing Countries
disparities
Early Detection of Cancer - standards
Global Health
Health Services Accessibility - standards
Healthcare Disparities - statistics & numerical data
Hepatitis B virus
Humans
low‐ and middle‐income countries
Neoplasms - ethnology
Neoplasms - prevention & control
Nursing
prevention
radiotherapy
Registries
Residence Characteristics
Rural Health
surgery
Urban Health
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Disparities in cancer control exist in low‐ and middle‐income countries (LMICs). Many countries do not have cancer registries to record incidence, mortality and prevalence and are reliant on Globocan estimates of their cancer burden. Poorer cancer control within and between countries occurs in those living remotely from urban centres, those in a low socioeconomic group and some ethnic groups who have lifestyle and belief systems which impact on cancer control. High‐income countries generally have population screening programmes for cervix, breast and bowel cancer. However, simpler forms of screening for cancer of the cervix like visual inspection with acetic acid have been shown to be feasible in developing nations. The widespread use of vaccines to prevent cancer has been achieved with the Hepatitis B vaccine but the human papilloma virus vaccine to prevent cancer of the cervix is largely only available in high‐income countries. Access to and training of oncological surgeons in LMICs is limited, while 70% of patients in these countries cannot access radiotherapy. The World Health Organization has developed a list of essential medicines although access remains poor in LMICs. The United Nations has set targets for the control of non‐communicable diseases to improve global cancer control.
ISSN:0961-5423
1365-2354
DOI:10.1111/ecc.12654